International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.12781429
Original Research Article
Functional outcome of conservative vs Intramedullary nailing incase of both bone forearm fracture in children- A comparitive study in Al-Ameen Medical College Hospital
Published
Feb. 18, 2025
Abstract

Background: Both bone diaphyseal fractures of the forearm are common injuries in children. This study aimed to compare the functional outcomes and complications of conservative management and surgical treatment with titanium elastic nailing system (TENS) for these fractures. Methods: A total of 40 children (aged 4-14 years) with both bone diaphyseal fractures of the forearm were included in this study. Twenty patients were treated conservatively, and 20 underwent surgical treatment with TENS nailing. Functional outcomes, time to union, and complications were assessed at 6 months post-treatment. Results: The surgical group had a significantly higher proportion of patients aged ≥ 10 years (75% vs. 15%; p=0.0001) and required longer duration of surgery (95% requiring 90 minutes vs. 100% requiring < 20 minutes; p<0.001). The mean time to union was significantly shorter in the surgical group (6.70 ± 1.867 weeks) compared to the conservative group (8.80 ± 1.642 weeks) (p=0.01). The functional outcome at 6 months was excellent in 90% and good in 10% of the surgical group, compared to 80% excellent and 20% good in the conservative group (p=0.3753). Complication rates were minimal and comparable between the two groups (p=0.1060). Conclusion: TENS nailing is an effective treatment option for both bone diaphyseal fractures of the forearm in children, particularly in older children, providing faster union times with comparable functional outcomes and complication rates to conservative management.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
2942 Views
300 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved